Please use this identifier to cite or link to this item:
Title: Pancreatic Organoids for Regenerative Medicine and Cancer Research
Author: Casamitjana, Joan
Espinet, Elisa
Rovira, Meritxell
Keywords: Malalties del pàncrees
Medicina regenerativa
Pancréas diseases
Regenerative medicine
Issue Date: 3-May-2022
Publisher: Frontiers Media
Abstract: In recent years, the development of ex vivo organoid cultures has gained substantial attention as a model to study regenerative medicine and diseases in several tissues. Diabetes and pancreatic ductal adenocarcinoma (PDAC) are the two major devastating diseases affecting the pancreas. Suitable models for regenerative medicine in diabetes and to accurately study PDAC biology and treatment response are essential in the pancreatic field. Pancreatic organoids can be generated from healthy pancreas or pancreatic tumors and constitute an important translational bridge between in vitro and in vivo models. Here, we review the rapidly emerging field of pancreatic organoids and summarize the current applications of the technology to tissue regeneration, disease modelling, and drug screening.
Note: Reproducció del document publicat a:
It is part of: Frontiers in Cell and Developmental Biology, 2022, vol. 10
Related resource:
ISSN: 2296-634X
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
fcell-10-886153.pdf1.63 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons